Search Results - Matteo Incerti
- Showing 1 - 10 results of 10
-
1
-
2
-
3
-
4
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma by Mirko Rivara, Gabriella Nicolini, Alessio Malacrida, Francesca Re, Matteo Incerti, Giulia Russo, Valentina Zuliani
Published in Results in Chemistry (2024-07-01)Get full text
Article -
5
-
6
-
7
Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph–Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavaila... by Francesca Ferlenghi, Carmine Giorgio, Matteo Incerti, Lorenzo Guidetti, Paola Chiodelli, Marco Rusnati, Massimiliano Tognolini, Federica Vacondio, Marco Mor, Alessio Lodola
Published in Pharmaceuticals (2021-12-01)Get full text
Article -
8
4-Thiazolidinone Derivatives as MMP Inhibitors in Tissue Damage: Synthesis, Biological Evaluation and Docking Studies by Matteo Incerti, Lucia Crascì, Paola Vicini, Esin Aki, Ismail Yalcin, Tugba Ertan-Bolelli, Venera Cardile, Adriana Carol Eleonora Graziano, Annamaria Panico
Published in Molecules (2018-02-01)Get full text
Article -
9
Probucol treatment is associated with an ABCA1-independent mechanism of cholesterol efflux to lipid poor apolipoproteins from foam cell macrophages by Anouar Hafiane, MSc, PhD, Alessandro Pisaturo, MSc, Annalisa Ronca, Matteo Incerti, PhD, Robert S. Kiss, PhD, Elda Favari, PhD
Published in BBA Advances (2021-01-01)Get full text
Article -
10
Evaluation of the Anti-Tumor Activity of Small Molecules Targeting Eph/Ephrins in APC <sup>min</sup>/J Mice by Miriam Corrado, Carmine Giorgio, Elisabetta Barocelli, Giuseppe Vittucci Marzetti, Anna Maria Cantoni, Rosanna Di Lecce, Matteo Incerti, Riccardo Castelli, Alessio Lodola, Massimiliano Tognolini
Published in Pharmaceuticals (2020-04-01)Get full text
Article
